Home » Health » With Efficacy Reaching 94.1%, Moderna Vaccine Receives BPOM Permit

With Efficacy Reaching 94.1%, Moderna Vaccine Receives BPOM Permit

There are already four imported vaccines that have permits for their use by the Food and Drug Supervisory Agency (BPOM).

Finally, there is AstraZeneca which has been disseminated to the people of the Republic of Indonesia (RI). Now there is one more vaccine name that has been granted permission to use it by BPOM, Moderna.

Popmama.com will tell Papa and Mama all at home, about the licensing of the latest vaccine called Moderna from the United States (US).

1. Official Moderna Permit issued by BPOM

1. Official Moderna Permit issued by BPOM

Unsplash/Ian Hutchinson

Launching from IDN Times, the emergency use of the Covid-19 vaccine, named Moderna, was officially issued by BPOM.

The head of BPOM, Penny Lukito, who explained that the permit for this vaccine was allowed.

Moderna is intended for the 18-65 year age group with efficacy or efficacy of 94.1 percent.

“Yesterday we added another type of COVID-19 vaccine that the UAE has received from BPOM Indonesia, the Moderna Covid-19 Vaccine,” he said at an online vua press conference, Friday (2/7).

Editors’ Picks

2. It has been reviewed for safe use by BPOM and ITAGI

2. It has been tested for user safety by BPOM ITAGI

Unsplash/Spencer Davis

Later, the vaccine will be injected with a 0.5 ml dose of intramuscular injection twice, with a span of one month.

Penny explained that in general the safety of the vaccine was tolerable, it was obtained from the results of the BPOM study with the Indonesian Technical Advisory Group on Immunization (ITAGI) and a number of parties.

“Both local and systemic reactions with local reactions with severity grades one and two, with the most frequent occurrences being pain, fatigue, headaches, muscle aches, these events are generally obtained after the second injection,” he said again.

3. Safe for vaccine recipient profiles with specific congenital diseases

3. Safe for congenital disease-specific vaccine recipient profiles

Freepik / press photo

Moderna as a vaccine which also shows high efficacy, has shown a safety profile in population groups with comorbidities.

What is meant is that it can be given or is classified as safe for individuals with chronic lung disease, heart disease, severe obesity, diabetes, liver disease, and HIV.

“The modern vaccine is the first vaccine to receive the UAE from BPOM using the mRNA platform,” said Penny again.

4. Get to know the Moderna vaccine

4. Get to know the Moderna vaccine

Unsplash/Spencer Davis

Moderna vaccine is a vaccine to prevent infection with Covid-19. The Moderna vaccine or mRNA-1273 was developed in January 2020 by the Moderna and Vaccine Research Center at the National Institute of Allergy and Infectious Disease (NIAID) in America.

Moderna vaccine is a type of mRNA (messenger RNA) vaccine. This vaccine does not use a weakened or killed virus, but uses a component of genetic material that makes the immune system produce spike proteins. The protein is part of the surface of the Corona virus.

Moderna vaccine is a vaccine that is the result of messenger ribonucleic acid (mRNA) technology and is intended for the 18-65 year age group with efficacy or efficacy showing 94.1 percent and 86.4 percent for those over 65 years of age.

Meanwhile, during June 2021, BPOM has issued UAE permits for the CoronaVac, AstraZeneca, Bio Farma and Sinopaharm vaccines.

Also read:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.